HCi Viocare announced that the board of directors of the company has appointed Yannis Levantis as a member of the board of directors of the company. The appointment comes at a time of operational growth for the company, which is currently establishing a chain of Prosthetic, Orthotic and Diabetic foot rehabilitation centres in Europe, and expanding its R&D portfolio of devices for the larger health & wellness industry. Over the most recent five years Mr. Levantis has been employed as the Global IT director (Rolls Royce PLC – Aerospace, Defence & Power Systems July 2011 to present and GlaxoSmithKline, Pharmaceutical January 2008 to June 2011) undertaking such rolls as global SAP-ERP design and delivery, delivering IT strategy and IT enabled business transformation programs supporting various business functions including supply chain purchasing, finance, quality and HR.

On June 11, 2015, the company entered into a loan agreement with the company's CEO, President and Director, Sotirios Leontaritis, (the Lender), whereby the Lender, in order to provide general working capital and to allow the company to effectuate its business plan, agreed to provide the company a loan facility of €150,000 with an annual interest of 5%, payable on maturity, and the company agreed to repay the loan within 5 years from the date of the loan agreement.